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Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S46accounted for by differences in DNA methylation of the +37 CpG site
that could inﬂuence the penetrance of rs143383 in susceptibility to OA
and in other common musculoskeletal diseases.
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ALLELIC EXPRESSION ANALYSIS IN PATIENT TISSUES OF THE
OSTEOARTHRITIS AND OF THE LUMBAR DISC HERNIATION
SUSCEPTIBILITY LOCI THAT MAP TO COL11A1
A.W. Dodd, E.V. Raine, L.N. Reynard, J. Loughlin. Newcastle Univ.,
Newcastle upon Tyne, United kingdom
Purpose: The arcOGEN genome-wide association scan (GWAS) has
generated evidence of association to OA of single nucleotide poly-
morphism (SNP) rs2615977 fromwithin intron 31 of COL11A1. This gene
codes for the a1 polypeptide chain of type XI collagen and has long been
considered a strong candidate for OA susceptibility, based on the
important structural role of type XI collagen in the cartilage extracel-
lular matrix and on the observation that penetrant mutations of
COL11A1 can cause Stickler's syndrome, which is a rare disease char-
acterized by severe early-onset secondary OA. Furthermore, a common
exonic SNP of COL11A1, rs1676486, has been reported to be associated
with lumbar disc herniation (LDH) in a Japanese population. LDH, like
OA, is a degenerative musculoskeletal condition whose prevalence
increases with age. Unlike rare diseases, many common complex traits
are mediated by cis-acting regulatory polymorphisms that inﬂuence
gene transcription or transcript stability, resulting in allelic expression
imbalance. The LDH SNP rs1676486 is an example of such a poly-
morphism, with the LDH-associated T allele of the SNP mediating
decreased stability of the COL11A1 transcript relative to the C allele. In
this study we therefore set out to assess: 1) whether the OA association
to rs2615977 was marking allelic expression imbalance of COL11A1 and
2) whether the detrimental effect that rs1676486 has on COL11A1
transcript expression in LDH is also observed in the cartilage of OA
patients.
Methods: Using RNA extracted from the cartilage of OA patients who
had undergone elective joint replacement surgery, we assessed
whether either SNP correlated with COL11A1 allelic expression by: 1)
measuring COL11A1 expression by quantitative PCR and then strati-
fying the data by genotype at each SNP in turn and 2) accurately
discriminating and quantifying the mRNA synthesized from both
alleles of each SNP, using allelic-quantitative PCR performed on
heterozygous patients. We studied a total of 73 male and female
patients, who had undergone either a hip or a knee replacement.
Linear regression was used to assess whether COL11A1 expression
relative to genotype differed signiﬁcantly from the null, whilst a 2-
tailed Mann-Whitney exact test was used to assess the signiﬁcance of
any allelic differences.
Results: We found no evidence for a correlation between COL11A1
expression levels and genotype at either SNP, nor were there any
correlations when the patients were stratiﬁed by the joint replaced
(all P-values were greater than 0.05). This stratiﬁcation analysis is
vulnerable to the natural variability in gene expression between
individuals, which can decrease its sensitivity and accuracy. For
example, in individuals of the same genotype we observed up to
a 250-fold difference in COL11A1 expression. The direct measurement
of allelic output is not vulnerable to such effects. In our allelic
expression analysis we found no evidence that genotype at the OA
associated SNP rs2615977 correlated with allelic expression imbal-
ance. However, we detected a complete correlation between allelic
expression imbalance and genotype at the LDH associated SNP
rs1676486: in all of the patients that we studied who were hetero-
zygous for this SNP the LDH associated T allele produced signiﬁcantly
less transcript than the C allele, with an average allelic ratio of 0.36
and P-value less than 0.0001. When we tested this SNP for association
in the arcOGEN GWAS of 7,410 cases and 11,009 controls, we did not
however detect any compelling evidence of association to OA (all
P-values were greater than 0.01).
Conclusions: In the tissues that we have studied our data does not
support the OA association signal at COL11A1, which is marked by SNP
rs2615977, as mediating an effect on the expression of the COL11A1
mRNA. However, the LDH SNP rs1676486 does mediate an effect on
COL11A1 expression in the same direction as that seen in LDH, but this
is not a risk factor for OA. Overall, COL11A1 can tolerate polymorphism
in its expression in hip or knee cartilage without this acting as a risk
factor for OA, something not seen in LDH.77
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Purpose: A strong genetic contribution to osteoarthritis (OA) is widely
recognized although few loci have yet to be robustly associated with
knee OA susceptibility. To identify genes associated with knee OA, we
performed joint analyses across two large North American cohorts with
well-characterized phenotypes of knee OA: the Genetic Components of
Knee OA (GeCKO) Study, an ancillary study from the Osteoarthritis
Initiative (OAI), and the Johnston County (JoCo) Osteoarthritis Project.
Our goals were to 1) attempt replication of 14 single nucleotide poly-
morphisms (SNPs) previously reported in the literature to be associated
with hip or knee OA, and 2) conduct an agnostic genome-wide asso-
ciation (GWA) analysis.
Methods: Cases had at least one knee with deﬁnite radiographic OA,
deﬁned as the presence of deﬁnite osteophytes (OARSI grade 1)
regardless of the presence of joint space narrowing (equivalent to
Kellgren-Lawrence [KL] grade >2). Controls were required to be free of
radiographic evidence of OA in both knees (i.e., no evidence of both
osteophytes and joint space narrowing, or KL grade¼ 0). Based on these
deﬁnitions, there were 1,920 and 761 Caucasian cases in the GeCKO-OAI
and JoCo cohorts, and 885 and 634 controls, respectively, included in
the analyses. The 14 SNPs selected for replication were identiﬁed
through a review of candidate gene and GWA studies in the literature.
Genotyping was carried out on the Illumina 2.5M and 1M arrays in
GeCKO-OAI and JoCo, respectively. Association analyses were carried
out separately in each cohort with adjustments for age and sex.
Results: None of the 14 previously reported genetic variants for OA
achieved even nominal signiﬁcance (p<0.05) with knee OA in the
GeCKO-OAI sample, despite a power to detect odds ratios of 1.17 or
greater. A hypothesis-free GWA analysis was then carried out in the
GeCKO-OAI sample on the 1.3M SNPs that passed genotype cleaning
ﬁlters. No SNPs were associated with knee OA at GWA levels of statis-
tical signiﬁcance (P < 5x10-8). However, a total of 155 SNPs, repre-
senting 54 different chromosome regions, were suggestively associated
with knee OA at a threshold of P < 10-4. We then tested these SNPs for
association with knee OA in cases and controls from the JoCo Study. Of
the 87 SNPs available for replication in JoCo, none were signiﬁcantly
associated with knee OA at a nominal P < 0.01. At our tested levels of
signiﬁcance (i.e., P < 10-4 in GeCKO-OAI and P < 0.01 in JoCo), we
estimated that our sample would have 80% power to detect SNPs having
odds ratios of 1.34 or higher among all SNPs tested in GeCKO-OAI and
for the subset of SNPs tested for replication in JoCo for disease allele
frequencies of 0.20 or greater.
Conclusions: Our ﬁndings support the polygenic nature of the genetic
contribution to knee OA and the likelihood that contributing loci are
likely to have very small effects. While it is potentially challenging to
harmonize OA case and control deﬁnitions between different studies,
ongoing meta-analyses may best be able to accommodate the complex
genetic architecture of OA.
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THE IDENTIFICATION OF TRANS-ACTING FACTORS THAT
DIFFERENTIALLY REGULATE THE EXPRESSION OF GDF5 VIA THE
OSTEOARTHRITIS ASSOCIATED SNP RS143383
C.M. Syddall, L.N. Reynard, D.A. Young, J. Loughlin. Newcastle Univ.,
Newcastle upon Tyne, United Kingdom
Purpose: A single nucleotide polymorphism (SNP), rs143383, in the
growth and differentiation factor 5 (GDF5) gene has been widely
studied, with the T-allele of the SNP being associated with an increased
risk of osteoarthritis (OA) and of a number of other common muscu-
loskeletal diseases. The effect of the SNP on gene function has been
investigated with the T-allele producing less GDF5 transcript in
comparison with the C-allele, both in-vitro and in-vivo, a phenomenon
known as allelic expression imbalance (AEI). The aim of this study was
to identify the trans-acting regulatory factors responsible for this
rs143383-mediated GDF5 AEI.
